19.01.2018
:
- AG 1, 349
- 2, 190.6
- 1, 134.35
- AG 348
- SUPER 229
- 156.9
. 200 /5 . 90 100.5 bosnalijek
. 100 30 90.5 bosnalijek
. /. 100 575 bayer consumer
. /. 30 203.9 bayer consumer
- . 10 30 56.1
. . 100 50 35.2
- - /. 1 / . 1 1 138.1 teva
. 100 211
16 FR, 18.8 nantong angel
14 FR, 23.3 nantong angel
4 - -
75 - -
5, - -
2030, 3, - -
2030, 2, - -
2030, 1, - -
- 4, 344
- 3, - -
- 2, - -
15 2,7 1 12.3
20 2,7 1 16.4
10 2,7 1 8.6
1010, 3, - -
- . 3000000 ., . ( /.) 5 - -
- . /- /. 3000000 ., . ( /.) 5 283.4
- . /- /. 1000000 ., . ( /.) 5 138.8
- . /- /. 3000000 . 10 515
- . /- /. 1000000 . 10 259.3
. /. 600 10 - pfizer inc -
- /. 2 / - / . 300 1 1197.9 pfizer inc
- . /- /. 20 / . 10 1 433 teva
- . /- /. 20 / . 5 1 159.6 teva
OMRON R1 - omron-
. 25 / + 250 / 120 694.48 glaxosmithklin
. 25 / + 125 / 120 486 glaxosmithklin
. 48 144.5 bittner
. 12 78.4 bittner
. 48 221.6 bittner
. 12 97 bittner
. /. 175 /5 ., 115 129.4 krka
10 - -
10 - -
BOGMARK 0,6 30 , (23G 1 1/4) 100 - medical lomza-
400 5 149
- . /- /. 0,1 % . 10 10 352
. 40 281.3 bittner
. 20 175.2 bittner
. 48 339.2 bittner
. 12 113.3 bittner
0,25 / . 5 , - 26.5
. 0,5 10 2.7
. /- / 440 ., . . 20 1 - roche -
. /- / 150 . 1 18693 roche
- . 50 118 heel
. 48 219 bittner
. 12 66 bittner
H NP /. 100 / . 10 274.5
H 30/70 /. 100 / . 10 274.6
H - /. 100 / . 10 202.35
- . 20 - sopharma -
. 300 30 168.8
- 40 / . 10 12.7
- /. 30 / . 1 5 56
- /. 5 / . 1 10 66
- /. 5 / . 1 5 32.4
- 75 , /, 28.5
. 130 - -
- 40 - -
1020, 3, - -
1020, 2, - -
1010, 2, - -
2033, 5, - -
2033, 4, - -
1 - -
3, / 118
2, / - -
3, - -
2033, 2, - -
5 - -
4 - -
3 - -
- 2010, 4 269.4
- 2010, 3 - -
- 2010, 2 - -
C 500 . . 0,5 , 30 25.9
C 500 . . 0,5 , 30 30.1
C 500 . . 0,5 , 10 9
E . 0,2 30 65.9
A . 33000 50 36.3
A . 33000 10 5.98
. 10 6 274.7 medinova
. . . 50 1 138.6 bionorica
. . 30 - bionorica -
. /. 50 133.3 bionorica
 

0.. - 230 - 231 - 232 - 233 - 234 - 235 - 236 - ..275


, ,
, , (c) , , 067-9566747